Back to Search
Start Over
Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling.
- Source :
-
BMC biology [BMC Biol] 2021 Mar 24; Vol. 19 (1), pp. 57. Date of Electronic Publication: 2021 Mar 24. - Publication Year :
- 2021
-
Abstract
- Background: Mitochondrial dysfunction is a common feature of aging, neurodegeneration, and metabolic diseases. Hence, mitotherapeutics may be valuable disease modifiers for a large number of conditions. In this study, we have set up a large-scale screening platform for mitochondrial-based modulators with promising therapeutic potential.<br />Results: Using differentiated human neuroblastoma cells, we screened 1200 FDA-approved compounds and identified 61 molecules that significantly increased cellular ATP without any cytotoxic effect. Following dose response curve-dependent selection, we identified the flavonoid luteolin as a primary hit. Further validation in neuronal models indicated that luteolin increased mitochondrial respiration in primary neurons, despite not affecting mitochondrial mass, structure, or mitochondria-derived reactive oxygen species. However, we found that luteolin increased contacts between mitochondria and endoplasmic reticulum (ER), contributing to increased mitochondrial calcium (Ca <superscript>2+</superscript> ) and Ca <superscript>2+</superscript> -dependent pyruvate dehydrogenase activity. This signaling pathway likely contributed to the observed effect of luteolin on enhanced mitochondrial complexes I and II activities. Importantly, we observed that increased mitochondrial functions were dependent on the activity of ER Ca <superscript>2+</superscript> -releasing channels inositol 1,4,5-trisphosphate receptors (IP <subscript>3</subscript> Rs) both in neurons and in isolated synaptosomes. Additionally, luteolin treatment improved mitochondrial and locomotory activities in primary neurons and Caenorhabditis elegans expressing an expanded polyglutamine tract of the huntingtin protein.<br />Conclusion: We provide a new screening platform for drug discovery validated in vitro and ex vivo. In addition, we describe a novel mechanism through which luteolin modulates mitochondrial activity in neuronal models with potential therapeutic validity for treatment of a variety of human diseases.
- Subjects :
- Animals
Cell Line, Tumor
Drug Evaluation, Preclinical
Endoplasmic Reticulum metabolism
High-Throughput Screening Assays
Humans
Mice
Mitochondria metabolism
Neurons drug effects
Signal Transduction
Endoplasmic Reticulum drug effects
Luteolin pharmacology
Mitochondria drug effects
Neurons metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1741-7007
- Volume :
- 19
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMC biology
- Publication Type :
- Academic Journal
- Accession number :
- 33761951
- Full Text :
- https://doi.org/10.1186/s12915-021-00979-5